Quarterly report · Q1
2796.TEDINET S100S04W
Period2023-06-01 → 2023-08-31
Filed2023-10-11
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 34
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥13.5bn | 2023-06-01 → 2023-08-31 | Cons. | Net sales |
| Revenue | ¥52.0bn | 2022-06-01 → 2023-05-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥12.9bn | 2022-06-01 → 2022-08-31 | Cons. | Net sales |
| Operating income | ¥331m | 2023-06-01 → 2023-08-31 | Cons. | Operating income |
| Operating income | ¥348m | 2022-06-01 → 2022-08-31 | Cons. | Operating income |
| Ordinary income | ¥331m | 2023-06-01 → 2023-08-31 | Cons. | Ordinary income |
| Ordinary income | ¥1.4bn | 2022-06-01 → 2023-05-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥341m | 2022-06-01 → 2022-08-31 | Cons. | Ordinary income |
| Profit before tax | ¥312m | 2023-06-01 → 2023-08-31 | Cons. | Income before income taxes |
| Profit before tax | ¥318m | 2022-06-01 → 2022-08-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥123m | 2023-06-01 → 2023-08-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥333m | 2022-06-01 → 2023-05-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥111m | 2022-06-01 → 2022-08-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥127m | 2023-06-01 → 2023-08-31 | Cons. | Profit loss |
| Net income | ¥114m | 2022-06-01 → 2022-08-31 | Cons. | Profit loss |
| Total assets | ¥23.6bn | at 2023-08-31 | Cons. | Assets |
| Total assets | ¥23.4bn | at 2023-05-31 | Cons. | Assets |
| Total assets | ¥23.2bn | at 2022-08-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥16.6bn | at 2023-08-31 | Cons. | Liabilities |
| Total liabilities | ¥16.4bn | at 2023-05-31 | Cons. | Liabilities |
| Net assets / equity | ¥7.0bn | at 2023-08-31 | Cons. | Net assets |
| Net assets / equity | ¥7.0bn | at 2023-05-31 | Cons. | Net assets |
| Net assets / equity | ¥6.7bn | at 2022-08-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥4.9bn | at 2023-08-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥4.7bn | at 2023-05-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥13.11 | 2023-06-01 → 2023-08-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥35.45 | 2022-06-01 → 2023-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥11.88 | 2022-06-01 → 2022-08-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥9.93 | 2023-06-01 → 2023-08-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥26.89 | 2022-06-01 → 2023-05-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥8.99 | 2022-06-01 → 2022-08-31 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 28.3% | at 2023-08-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 28.5% | at 2023-05-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 27.6% | at 2022-08-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 44
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2023-06-01 → 2023-08-31 | ¥185m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2023-06-01 → 2023-08-31 | ¥185m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-06-01 → 2023-08-31 | ¥0 |
| Reconciling Itemsreconciling | segment profit | 2023-06-01 → 2023-08-31 | −¥78m |
| jpcrp040300-q1r_E05379-000Cosmetic Drug And Convenience Storereportable segment | revenue | 2023-06-01 → 2023-08-31 | ¥2.1bn |
| jpcrp040300-q1r_E05379-000Cosmetic Drug And Convenience Storereportable segment | revenue external | 2023-06-01 → 2023-08-31 | ¥2.1bn |
| jpcrp040300-q1r_E05379-000Cosmetic Drug And Convenience Storereportable segment | segment profit | 2023-06-01 → 2023-08-31 | −¥9m |
| jpcrp040300-q1r_E05379-000Custody Of Medical Documentsreportable segment | revenue | 2023-06-01 → 2023-08-31 | ¥155m |
| jpcrp040300-q1r_E05379-000Custody Of Medical Documentsreportable segment | revenue external | 2023-06-01 → 2023-08-31 | ¥155m |
| jpcrp040300-q1r_E05379-000Custody Of Medical Documentsreportable segment | segment profit | 2023-06-01 → 2023-08-31 | ¥11m |
| jpcrp040300-q1r_E05379-000Dispensing Pharmacyreportable segment | revenue | 2023-06-01 → 2023-08-31 | ¥10.9bn |
| jpcrp040300-q1r_E05379-000Dispensing Pharmacyreportable segment | revenue external | 2023-06-01 → 2023-08-31 | ¥10.9bn |
| jpcrp040300-q1r_E05379-000Dispensing Pharmacyreportable segment | segment profit | 2023-06-01 → 2023-08-31 | ¥379m |
| jpcrp040300-q1r_E05379-000Medical Mallreportable segment | revenue | 2023-06-01 → 2023-08-31 | ¥126m |
| jpcrp040300-q1r_E05379-000Medical Mallreportable segment | revenue external | 2023-06-01 → 2023-08-31 | ¥126m |
| jpcrp040300-q1r_E05379-000Medical Mallreportable segment | segment profit | 2023-06-01 → 2023-08-31 | ¥27m |
| —segment total | revenue | 2023-06-01 → 2023-08-31 | ¥13.3bn |
| —segment total | revenue external | 2023-06-01 → 2023-08-31 | ¥13.3bn |
| —segment total | segment profit | 2023-06-01 → 2023-08-31 | ¥408m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-06-01 → 2023-08-31 | ¥13.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-06-01 → 2023-08-31 | ¥13.5bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-06-01 → 2023-08-31 | ¥409m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-06-01 → 2022-08-31 | ¥204m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-06-01 → 2022-08-31 | ¥204m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-06-01 → 2022-08-31 | ¥21m |
| Reconciling Itemsreconciling | segment profit | 2022-06-01 → 2022-08-31 | −¥75m |
| jpcrp040300-q1r_E05379-000Cosmetic Drug And Convenience Storereportable segment | revenue | 2022-06-01 → 2022-08-31 | ¥2.0bn |
| jpcrp040300-q1r_E05379-000Cosmetic Drug And Convenience Storereportable segment | revenue external | 2022-06-01 → 2022-08-31 | ¥2.0bn |
| jpcrp040300-q1r_E05379-000Cosmetic Drug And Convenience Storereportable segment | segment profit | 2022-06-01 → 2022-08-31 | −¥35m |
| jpcrp040300-q1r_E05379-000Custody Of Medical Documentsreportable segment | revenue | 2022-06-01 → 2022-08-31 | ¥169m |
| jpcrp040300-q1r_E05379-000Custody Of Medical Documentsreportable segment | revenue external | 2022-06-01 → 2022-08-31 | ¥169m |
| jpcrp040300-q1r_E05379-000Custody Of Medical Documentsreportable segment | segment profit | 2022-06-01 → 2022-08-31 | ¥20m |
| jpcrp040300-q1r_E05379-000Dispensing Pharmacyreportable segment | revenue | 2022-06-01 → 2022-08-31 | ¥10.4bn |
| jpcrp040300-q1r_E05379-000Dispensing Pharmacyreportable segment | revenue external | 2022-06-01 → 2022-08-31 | ¥10.4bn |
| jpcrp040300-q1r_E05379-000Dispensing Pharmacyreportable segment | segment profit | 2022-06-01 → 2022-08-31 | ¥398m |
| jpcrp040300-q1r_E05379-000Medical Mallreportable segment | revenue | 2022-06-01 → 2022-08-31 | ¥126m |
| jpcrp040300-q1r_E05379-000Medical Mallreportable segment | revenue external | 2022-06-01 → 2022-08-31 | ¥126m |
| jpcrp040300-q1r_E05379-000Medical Mallreportable segment | segment profit | 2022-06-01 → 2022-08-31 | ¥19m |
| —segment total | revenue | 2022-06-01 → 2022-08-31 | ¥12.7bn |
| —segment total | revenue external | 2022-06-01 → 2022-08-31 | ¥12.7bn |
| —segment total | segment profit | 2022-06-01 → 2022-08-31 | ¥402m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-06-01 → 2022-08-31 | ¥12.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-06-01 → 2022-08-31 | ¥12.9bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-06-01 → 2022-08-31 | ¥424m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 375
| Item | Context | Value | Unit |
|---|---|---|---|
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant | 321100 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant | － | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant | 321100 | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant | 0.033 | |
| Cash and deposits | Prior1YearInstant | 4742000000 | JPY |
| Cash and deposits | CurrentQuarterInstant | 4877000000 | JPY |
| Accounts receivable trade | Prior1YearInstant | 611000000 | JPY |
| Accounts receivable trade | CurrentQuarterInstant | 580000000 | JPY |
| Merchandise and finished goods | Prior1YearInstant | 2225000000 | JPY |
| Merchandise and finished goods | CurrentQuarterInstant | 3013000000 | JPY |
| Raw materials and supplies | Prior1YearInstant | 65000000 | JPY |
| Raw materials and supplies | CurrentQuarterInstant | 75000000 | JPY |
| Accounts receivable other | Prior1YearInstant | 3412000000 | JPY |
| Accounts receivable other | CurrentQuarterInstant | 2688000000 | JPY |
| Other ca | Prior1YearInstant | 320000000 | JPY |
| Other ca | CurrentQuarterInstant | 303000000 | JPY |
| Allowance for doubtful accounts ca | Prior1YearInstant | -6000000 | JPY |
| Allowance for doubtful accounts ca | CurrentQuarterInstant | -6000000 | JPY |
| Current assets | Prior1YearInstant | 11372000000 | JPY |
| Current assets | CurrentQuarterInstant | 11532000000 | JPY |
| Buildings and structures net | Prior1YearInstant | 2902000000 | JPY |
| Buildings and structures net | CurrentQuarterInstant | 2893000000 | JPY |
| Land | Prior1YearInstant | 2587000000 | JPY |
| Land | CurrentQuarterInstant | 2587000000 | JPY |
| Other net ppe | Prior1YearInstant | 519000000 | JPY |
| Other net ppe | CurrentQuarterInstant | 573000000 | JPY |
| Property plant and equipment | Prior1YearInstant | 6010000000 | JPY |
| Property plant and equipment | CurrentQuarterInstant | 6054000000 | JPY |
| Goodwill | Prior1YearInstant | 2748000000 | JPY |
| Goodwill | CurrentQuarterInstant | 2612000000 | JPY |
| Other ia | Prior1YearInstant | 502000000 | JPY |
| Other ia | CurrentQuarterInstant | 526000000 | JPY |
| Intangible assets | Prior1YearInstant | 3250000000 | JPY |
| Intangible assets | CurrentQuarterInstant | 3138000000 | JPY |
| Other ioa | Prior1YearInstant | 2940000000 | JPY |
| Other ioa | CurrentQuarterInstant | 3001000000 | JPY |
| Allowance for doubtful accounts ioa by group | Prior1YearInstant | -152000000 | JPY |
| Allowance for doubtful accounts ioa by group | CurrentQuarterInstant | -173000000 | JPY |
| Investments and other assets | Prior1YearInstant | 2787000000 | JPY |
| Investments and other assets | CurrentQuarterInstant | 2828000000 | JPY |
| Noncurrent assets | Prior1YearInstant | 12048000000 | JPY |
| Noncurrent assets | CurrentQuarterInstant | 12020000000 | JPY |
| Deferred assets | Prior1YearInstant | 0 | JPY |
| Deferred assets | CurrentQuarterInstant | 0 | JPY |
| Assets | Prior1YearInstant | 23421000000 | JPY |
| Assets | CurrentQuarterInstant | 23553000000 | JPY |
| Accounts payable trade | Prior1YearInstant | 4252000000 | JPY |
| Accounts payable trade | CurrentQuarterInstant | 4919000000 | JPY |
| Current portion of bonds | Prior1YearInstant | 1482000000 | JPY |
| Current portion of bonds | CurrentQuarterInstant | 1482000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |